SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 29th, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 29th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of December 28, 2020, is made by and among TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”). The capitalized terms used herein and not otherwise defined have the meanings given them in Article 6.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 22nd, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 22nd, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of December 21, 2020, is made by and among TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”). The capitalized terms used herein and not otherwise defined have the meanings given them in Article 6.